Shaul, Chanan
Blotnick, Simcha
Muszkat, Mordechai
Bialer, Meir
Caraco, Yoseph http://orcid.org/0000-0002-7959-2517
Clinical trials referenced in this document:
Documents that mention this clinical trial
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects
https://doi.org/10.1007/s40291-016-0247-7
Funding for this research was provided by:
United States-Israel Binational Science Foundation (2003229)
Article History
First Online: 22 November 2016
Compliance with Ethical Standards
:
: Chanan Shaul declares no conflicts of interest. Simcha Blotnick declares no conflicts of interest. Mordechai Muszkat declares no conflicts of interest. Meir Bialer declares no conflicts of interest. Yoseph Caraco declares no conflicts of interest.
: The corresponding author (YC) received a grant from the Bi-National US-Israeli Science Foundation (BSF) (Grant # 2003229).
: The study protocol was approved by the Hadassah Institutional Review Board and following a detailed explanation all subjects signed an informed consent (Approval number: Warfarin PK, 8-19.12.03).